Valneva SE Share Price London S.E.
Stocks
0OB3
FR0004056851
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.592 EUR | -38.30% |
|
+15.92% | -30.05% |
| Market Cap | 41Cr 47Cr 38Cr 35Cr 66Cr 4.51TCr 67Cr 450.97Cr 177.38Cr 2.21TCr 175.71Cr 171.86Cr 7.6TCr | P/E 2026 * |
-5.87x | P/E 2027 * | 5.67x |
|---|---|---|---|---|---|
| Enterprise Value | 54Cr 61Cr 50Cr 46Cr 86Cr 5.92TCr 88Cr 592.16Cr 232.91Cr 2.9TCr 230.72Cr 225.66Cr 9.97TCr | EV / Sales 2026 * |
3.54x | EV / Sales 2027 * | 1.59x |
| Free-Float |
97.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Valneva SE
| 1 day | -38.30% | ||
| 1 week | +15.92% | ||
| Current month | +14.71% | ||
| 1 month | +13.01% | ||
| 3 months | +0.26% | ||
| 6 months | -37.60% | ||
| Current year | -30.05% |
| 1 week | 2.1 |  | 2.59 |
| 1 month | 2.1 | | 2.59 |
| Current year | 2.1 | | 5.15 |
| 1 year | 2.1 | | 5.42 |
| 3 years | 1.72 | | 7.14 |
| 5 years | 1.72 | | 29.54 |
| 10 years | 1.72 | | 29.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | - | |
Peter Buhler
DFI | Director of Finance/CFO | 56 | 29/07/2021 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 20/12/2023 | |
James Sulat
BRD | Director/Board Member | 75 | 07/03/2013 |
| Chairman | 65 | 20/12/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -38.30% | +15.92% | - | - | 47Cr | |
| -1.29% | -3.11% | -0.35% | +2.64% | 4.92TCr | |
| +3.90% | -0.39% | +386.06% | +588.97% | 3.96TCr | |
| -1.70% | +4.46% | +5.93% | +61.54% | 3.47TCr | |
| -2.01% | -0.76% | +28.41% | -8.52% | 3.44TCr | |
| +0.06% | +0.34% | +2.38% | +34.47% | 2.71TCr | |
| +0.46% | -3.49% | - | - | 1.62TCr | |
| -0.04% | -0.09% | +72.42% | +116.45% | 1.54TCr | |
| +1.12% | +1.91% | +14.54% | +15.44% | 1.41TCr | |
| 0.00% | +1.36% | +18.43% | -31.23% | 1.3TCr | |
| Average | -3.78% | +0.03% | +65.98% | +97.47% | 2.71TCr | |
| Weighted average by Cap. | -0.13% | -0.18% | +79.44% | +122.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15Cr 17Cr 14Cr 13Cr 24Cr 1.67TCr 25Cr 167.45Cr 66Cr 819.38Cr 65Cr 64Cr 2.82TCr | 29Cr 34Cr 27Cr 25Cr 47Cr 3.24TCr 48Cr 324.31Cr 127.56Cr 1.59TCr 126.36Cr 123.59Cr 5.46TCr |
| Net income | -6.6Cr -7.55Cr -6.09Cr -5.61Cr -11Cr -727.46Cr -11Cr -73Cr -29Cr -356.28Cr -28Cr -28Cr -1.23TCr | 7.05Cr 8.07Cr 6.51Cr 6Cr 11Cr 776.9Cr 12Cr 78Cr 31Cr 380.5Cr 30Cr 30Cr 1.31TCr |
| Net Debt | 13Cr 15Cr 12Cr 11Cr 21Cr 1.41TCr 21Cr 141.19Cr 56Cr 690.89Cr 55Cr 54Cr 2.38TCr | 6Cr 6.87Cr 5.54Cr 5.1Cr 9.62Cr 661.37Cr 9.84Cr 66Cr 26Cr 323.91Cr 26Cr 25Cr 1.12TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | €2.152 | -1.14% | 20,185 |
| 16/26/16 | €2.177 | -0.80% | 23,994 |
| 15/26/15 | €2.194 | +0.10% | 11,666 |
| 14/26/14 | €2.192 | -4.94% | 23,371 |
| 13/26/13 | €2.306 | +3.11% | 12,482 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VLA Stock
- 0OB3 Stock
Select your edition
All financial news and data tailored to specific country editions
